Trials / Unknown
UnknownNCT00449254
Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults
A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Oleoyl-Estrone (MP-101) in Male Obese Adults.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Manhattan Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center, multiple-dose, randomized, double-blind, three-arm, placebo-controlled study of fixed-dose repeated oral dosing for 30 days of 10 mg and 30 mg MP-101 and placebo in obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oleoyl-estrone (MP-101) |
Timeline
- Start date
- 2006-10-01
- First posted
- 2007-03-20
- Last updated
- 2007-06-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00449254. Inclusion in this directory is not an endorsement.